You generally cannot take Ozempic just to lose a few pounds if you're not overweight or have type 2 diabetes, as it's approved for diabetes and its weight loss effects are for people with obesity or excess weight with related conditions; doctors may prescribe it off-label for weight loss in specific cases, but for non-diabetic weight loss, alternatives like Wegovy (semaglutide) or Zepbound are approved, with strict BMI/comorbidity requirements. Using it for minor weight loss without medical necessity is risky and contributes to shortages, experts warn.
Experts still recommend that people avoid using Ozempic unless they have type 2 diabetes. Instead, talk to your health care provider about starting Wegovy for weight loss.
In contrast, certain antidepressants may worsen glycaemic control. Tricyclic antidepressants (TCAs) such as amitriptyline are associated with weight gain and potential insulin resistance, which may counteract the glucose-lowering effects of Ozempic.
Can Ozempic cause dizziness? Ozempic can make you feel dizzy, lightheaded, or jittery. These symptoms can also be signs that your blood sugar is too low. If you feel dizzy or have other signs of low blood sugar on this medicine, you should call your health care provider.
Do not use Ozempic® if: you or any of your family have ever had MTC or if you have MEN 2. you are allergic to semaglutide or any of the ingredients in Ozempic®. See symptoms of serious allergic reaction in “What are the possible side effects of Ozempic®?”.
Summary: 'Ozempic hands' refers to reported cosmetic changes in hand appearance—such as more visible veins, tendons, and bones—associated with weight loss during semaglutide treatment, though it is not an officially recognised medical condition.
We test pancreatic enzymes because the medication is associated with inflammation of the pancreas (pancreatitis), and we check a full blood count as semaglutide has been known to cause anaemia due to nutritional deficiencies related to reduced appetite.
Candidates for Ozempic treatment for weight loss include individuals who have a BMI of 30 or higher and those with a BMI of 27 or higher as well as at least one weight-related condition, such as high blood pressure, high cholesterol, or type 2 diabetes. Ozempic is not the right weight loss approach for everyone.
Please be aware that the 1.5 mL presentation of Ozempic 0.25 mg/0.5 mg pre-filled pen is being discontinued from 31 December 2025, and it will be Supply Only on the PBS until 1 June 2026. As such, you will only be able to write PBS prescriptions for the 3 mL presentation of Ozempic 0.25 mg/0.5 mg pre-filled pen.
Mounjaro and Ozempic both target appetite regulation and can lead to significant weight loss. The main difference is that Mounjaro, which works on both GLP-1 and GIP receptors, may offer enhanced results compared to Ozempic, which only targets the GLP-1 receptor.
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year. Studies suggest that most people discontinue their use due to the high cost and adverse gastrointestinal side-effects.
Ozempic® may cause serious side effects, including:
Q How should I take Ozempic®? The best places on your body to inject Ozempic® are the front of your thighs, the front of your waist (abdomen) or your upper arms. It is recommended that you rotate your injection site each time you inject.
“Ozempic starts working in the body shortly after the first dose, but noticeable improvements in blood sugar levels usually take a few weeks,” Dr. Tambini says. “Most people see a meaningful drop in blood sugar within 4–8 weeks, but the full effects can take up to three months as the dose is adjusted.”
Week 1–2: Subtle Appetite Shifts
In the first week after your initial dose, the effects of Ozempic begin to take hold. Many patients report: A noticeable drop in appetite. Less interest in snacking between meals.
Ozempic May Improve Your Sleep in Other Ways
Ozempic and other semaglutide drugs or tirzepatide drugs may improve your sleep outside of sleep apnea. They can help with obesity and diabetes — both of which are linked to sleep disturbances beyond sleep apnea.
Ozempic can also affect the reward centers in the brain that release dopamine, which gives people pleasure from eating certain kinds of foods. While on Ozempic, a person may find eating certain kinds of foods less gratifying, which can help reduce calorie intake during the day.
'Ozempic legs' is an informal term describing visible changes in leg appearance—such as reduced fat volume, increased muscle and vein visibility, and looser skin—that some people experience during treatment with semaglutide (Ozempic) or similar GLP-1 receptor agonists.